as of September 6, 2010
ADHD Corner
OVERVIEW
ADHD (Attention Deficit Hyperactivity Disorder) is a problem with inattentiveness, over-activity, impulsivity, or a combination. For these problems to be diagnosed as ADHD, they must be out of the normal range for the child's age and development.
CAUSES/RISK FACTORS
Neuroimaging studies suggest that the brains of children with ADHD are different from those of other children. These children handle neurotransmitters (including dopamine, serotonin, and adrenalin) differently from their peers.
ADHD is often genetic. Whatever the specific cause may be, it seems to be set in motion early in life as the brain is developing.
Attention Deficit Disorder (ADD) is the most commonly diagnosed behavioral disorder of childhood, affecting an estimated 3 - 5% of school aged children. It is diagnosed much more often in boys than in girls.
Most children with ADHD also have at least one other developmental or behavioral problem.
SYMPTOMS
To be diagnosed with ADHD, children should have at least 6 attention symptoms or 6 activity and impulsivity symptoms -- to a degree beyond what would be expected for children their age.
The symptoms must be present for at least 6 months, observable in 2 or more settings, and not caused by another problem. The symptoms must be severe enough to cause significant difficulties. Some symptoms must be present before age 7.
Inattention symptoms:
-Fails to give close attention to details or makes careless mistakes in schoolwork
-Difficulty sustaining attention in tasks or play
-Does not seem to listen when spoken to directly
-Does not follow through on instructions and fails to finish schoolwork, chores, or duties in the workplace
-Difficulty organizing tasks and activities
-Avoids or dislikes tasks that require sustained mental effort (such as schoolwork)
-Often loses toys, assignments, pencils, books, or tools needed for tasks or activities
-Easily distracted
-Often forgetful in daily activities
Hyperactivity symptoms:
-Fidgets with hands or feet or squirms in seat
-Leaves seat when remaining seated is expected
-Runs about or climbs in inappropriate situations
-Difficulty playing quietly
-Often "on the go," acts as if "driven by a motor," talks excessively
Impulsivity symptoms:
-Blurts out answers before questions have been completed
-Difficulty awaiting turn
-Interrupts or intrudes on others (butts into conversations or games)
CARE/TREATMENT
The American Academy of Pediatrics has guidelines for treating ADHD:
-Set specific, appropriate target goals to guide therapy.
-Medication and behavior therapy should be started.
-When treatment has not met the target goals, evaluate the original diagnosis, the possible presence of other conditions, and how well the treatment plan has been implemented.
-Systematic follow-up is important to regularly reassess target goals, results, and any side effects of medications. Information should be gathered from parents, teachers, and the child
The following may also help:
-Limit distractions in the child's environment.
-Provide one-on-one instruction with teacher.
-Make sure the child gets enough sleep.
-Make sure the child gets a healthy, varied diet, with plenty of fiber and basic nutrients.
PREVENTION
While there is no proven way to prevent ADHD itself, early identification and treatment can prevent many of the problems associated with ADHD.
Real Stories, Expert Advice
Health Corner Videos: ADHD
New Test Helps Doctors Make ADHD Diagnosis
Attention deficit hyperactivity disorder (ADHD) makes it hard to control behavior. It affects about 10 million Americans and diagnosing it can be tricky. But now there's a new test available. In the past, diagnosing ADHD was challenging because...
Resources
National Institute of Mental Health
American Academy of Pediatrics
National Resource Center on ADHD
In the News: ADHD
Actavis Receives FDA Approval Of Atomoxetine HCl Capsules
Thu, 02 Sep 2010 02:00:00 PDT
http://mnt.to/f/3Jbn
Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention deficit/hyperactivity disorder (ADHD). Actavis intends to market Atomoxetine HCl in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg strengths...
Sun Pharma Announces USFDA Approval For Generic Strattera(R) Capsules
Thu, 02 Sep 2010 00:00:00 PDT
http://mnt.to/f/3J9z
Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules...